Clicky

TabletWise.com
Pharmacy Website
Clinic Website
 

Intelligence » Amyotrophic Lateral Sclerosis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

[Articles] Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Thursday, December 13, 2018 -- In this proof-of-concept trial, nabiximols had a positive effect on spasticity symptoms in patients with motor neuron disease and had an acceptable safety and tolerability profile. These findings should be investigated further in larger clinical trials.